Iofina (LON:IOF – Get Free Report)‘s stock had its “buy” rating restated by equities research analysts at Canaccord Genuity Group in a research report issued to clients and investors on Friday, Digital Look reports. They currently have a GBX 70 target price on the stock. Canaccord Genuity Group’s target price would indicate a potential upside of 37.25% from the company’s previous close.
Iofina Stock Performance
Shares of Iofina stock traded down GBX 4 during trading hours on Friday, reaching GBX 51. 2,387,664 shares of the stock traded hands, compared to its average volume of 535,929. The company has a 50 day moving average price of GBX 52.71 and a 200 day moving average price of GBX 48.29. The firm has a market capitalization of £97.85 million, a price-to-earnings ratio of 11.33 and a beta of 0.96. Iofina has a one year low of GBX 20 and a one year high of GBX 60.12. The company has a quick ratio of 1.56, a current ratio of 2.57 and a debt-to-equity ratio of 10.80.
Iofina (LON:IOF – Get Free Report) last released its quarterly earnings results on Monday, September 21st. The company reported GBX 1.80 EPS for the quarter. Iofina had a net margin of 12.91% and a return on equity of 15.30%. On average, equities research analysts expect that Iofina will post 1.82 earnings per share for the current fiscal year.
Iofina Company Profile
Iofina plc is a vertically integrated company that specialises in the production of Iodine and the manufacturing of specialty chemical products and derivatives. Iofina is the second largest producer of iodine in North America and operates the manufacturing entities, Iofina Resources, and Iofina Chemical.
Featured Articles
- Five stocks we like better than Iofina
- Bank of America Stock Sell-Off Looks Like a Buying Opportunity
- AST SpaceMobile Is Down 67%—Could SpaceX’s Mobile Push Deepen the Selloff?
- GlobalFoundries’ $21 Billion Deal Could Change the Economics of Chipmaking
- Fundamental and Technicals Signals Align for Costco: Is the Stock Finally Breaking Out?
Receive News & Ratings for Iofina Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Iofina and related companies with MarketBeat.com's FREE daily email newsletter.
